Alterations of Ca2+-responsive proteins within cholinergic neurons in aging and Alzheimer's disease

Neurobiology of Aging

Volumn 35, Issue 6, 2014, Pages 1325-1333

  Riascos, David ^a   Nicholas, Alexander ^b   Samaeekia, Ravand ^a   Yukhananov, Rustam ^c   Mesulam, M Marsel ^a   Bigio, Eileen H ^a   Weintraub, Sandra ^a   Guo, Ling ^a   Geula, Changiz ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Precision Biosystems   (United States)

Author keywords

Basal forebrain; Calbindin D28K; Calpain; CaMKI; Cholinergic system; GAP43; Proteolysis

Indexed keywords

CALBINDIN 1; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CALPAIN; CALPAIN 1; NEUROMODULIN; RNA; SPECTRIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN LEVEL; CALCIUM SIGNALING; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOWN REGULATION; FOREBRAIN; HUMAN; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; DEFICIENCY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CALBINDIN 1; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CALPAIN; CHOLINERGIC NEURONS; FEMALE; GAP-43 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; PROSENCEPHALON; RNA; YOUNG ADULT;

EID: 84903365811     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.12.017     Document Type: Article

References (63)

1. Ageta-Ishihara N., Takemoto-Kimura S., Nonaka M., Adachi-Morishima A., Suzuki K., Kamijo S., Fujii H., Mano T., Blaeser F., Chatila T.A. Control of cortical axon elongation by a GABA-driven Ca2+/calmodulin-dependent protein kinase cascade. J.Neurosci. 2009, 29:13720-13729.
2. Aigner L., Arber S., Kapfhammer J., Laux T., Schneider C., Botteri F., Brenner H., Caroni P. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 1995, 83:269-278.
3. Aigner L., Caroni P. Depletion of 43-kD growth-associated protein in primary sensory neurons leads to diminished formation and spreading of growth cones. J.Cell Biol. 1993, 123:417-429.
4. Augood S., Arbuthnott G., Emson P. Identified cholinergic neurones in the adult rat brain are enriched in GAP-43 mRNA: a double in situ hybridisation study. J.Chem. Neuroanat. 1995, 9:17-26.
5. Bell K., Bent R., Meese-Tamuri S., Ali A., Forder J., Aarts M. Calmodulin kinase IV-dependent CREB activation is required for neuroprotection via NMDA receptor-PSD95 disruption. J.Neurochem. 2013, 126:274-287.
6. Bu J., Sathyendra V., Nagykery N., Geula C. Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex. Exp. Neurol. 2003, 182:220-231.
7. Bullock R., Bergman H., Touchon J., Gambina G., He Y., Nagel J., Lane R. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Curr. Med. Res. Opin. 2006, 22:483-494.
8. Cafferty W., Gardiner N., Das P., Qiu J., McMahon S., Thompson S. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J.Neurosci. 2004, 24:4432-4443.
9. Czogalla A., Sikorski A. Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell Mol. Life Sci. 2005, 62:1913-1924.
10. Chang H.T., Kuo H. Relationship of calbindin D-28k and cholinergic neurons in the nucleus basalis of Meynert of the monkey and the rat. Brain Res. 1991, 549:141-145.
11. Chapman E., Au D., Alexander K., Nicolson T., Storm D. Characterization of the calmodulin binding domain of neuromodulin. Functional significance of serine 41 and phenylalanine 42. J.Biol. Chem. 1991, 266:207-213.
12. D'Orlando C., Fellay B., Schwaller B., Salicio V., Bloc A., Gotzos V., Celio M. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells. Brain Res. 2001, 909:145-158.
13. duVerle D., Takigawa I., Ono Y., Sorimachi H., Mamitsuka H. CaMPDB: a resource for calpain and modulatory proteolysis. Genome Inform. 2010, 22:202-213.
14. Figueiredo B., Skup M., Bedard A., Tetzlaff W., Cuello A. Differential expression of p140trk, p75NGFR and growth-associated phosphoprotein-43 genes in nucleus basalis magnocellularis, thalamus and adjacent cortex following neocortical infarction and nerve growth factor treatment. Neuroscience 1995, 68:29-45.
15. Gagliardini V., Dusart I., Fankhauser C. Absence of GAP-43 can protect neurons from death. Mol. Cell Neurosci. 2000, 16:27-33.
16. Gamby C., Waage M., Allen R., Baizer L. Analysis of the role of calmodulin binding and sequestration in neuromodulin (GAP-43) function. J.Biol. Chem. 1996, 271:26698-26705.
17. Geula C., Bu J., Nagykery N., Scinto L., Chan J., Joseph J., Parker R., Wu C. Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss. J.Comp. Neurol. 2003, 455:249-259.
18. Geula C., Mesulam M. Cholinergic systems in Alzheimer's disease. Alzheimer's disease 1999, 269-292. Lippincott, Williams, and Wilkins, Philadelphia, PA. R.D. Terry, R. Katzman, K.L. Bick, S.S. Sisodia (Eds.).
19. Geula C., Nagykery N., Nicholas A., Wu C.K. Early cholinergic neuronal and axonal pathology in aging and Alzheimer's disease. J.Neuropathol. Exp. Neurol. 2008, 67:309-318.
20. Geula C., Schatz C.R., Mesulam M.M. Differential localization of NADPH-diaphorase and calbindin-D within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 1993, 54:461-476.
21. Goll D., Thompson V., Taylor R., Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin?. Bioessays 1992, 14:549-566.
22. Goslin K., Schreyer D., Skene J., Banker G. Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature 1988, 336:672-674.
23. Gupta S., Mishra R., Kusum S., Spedding M., Meiri K., Gressens P., Mani S. GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986. Cell Death Differ. 2009, 16:624-637.
24. Harkany T., Abrahám I., Timmerman W., Laskay G., Tóth B., Sasvári M., Kónya C., Sebens J., Korf J., Nyakas C. Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur. J. Neurosci. 2000, 12:2735-2745.
25. Iacopino A., Christakos S. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A 1990, 87:4078-4082.
26. Iacopino A., Quintero E., Miller E. Calbindin-D28K: a potential neuroprotective protein. Neurodegeneration 1994, 3:1-20.
27. Ikonomovic M., Nocera R., Mizukami K., Armstrong D. Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert. Exp. Neurol. 2000, 166:363-375.
28. Kamata A., Sakagami H., Tokumitsu H., Owada Y., Fukunaga K., Kondo H. Spatiotemporal expression of four isoforms of Ca2+/calmodulin-dependent protein kinase I in brain and its possible roles in hippocampal dendritic growth. Neurosci. Res. 2007, 57:86-97.
29. Keswani S., Rosenberg B., Hoke A. The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures. J.Neurosci. Methods 2004, 136:193-195.
30. Lehericy S., Hirsch É., Cervera-Piérot P., Hersh L., Bakchine S., Piette F., Duyckaerts C., Hauw J., Javoy-Agid F., Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J.Comp. Neurol. 1993, 330:15-31.
31. Liang Z., Liu F., Grundke-Iqbal I., Iqbal K., Gong C. Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J.Neurochem. 2007, 103:2462-2470.
32. Liu J., Liu M.C., Wang K.K. Calpain in the CNS: from synaptic function to neurotoxicity. Sci. Signal 2008, 1. re1.
33. Masliah E., Mallory M., Hansen L., Alford M., Albright T., DeTeresa R., Terry R., Baudier J., Saitoh T. Patterns of aberrant sprouting in Alzheimer's disease. Neuron 1991, 6:729-739.
34. Mattson M. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
35. McGinnis K., Wang K., Gnegy M. Calcium/calmodulin-dependent protein kinase inhibition potentiates thapsigargin-mediated cell death in SH-SY5Y human neuroblastoma cells. Neurosci. Lett. 2001, 301:99-102.
36. McKinney R., Lüthi A., Bandtlow C., Gähwiler B., Thompson S. Selectiveglutamate receptor antagonists can induce or prevent axonal sprouting in rat hippocampal slice cultures. Pro Natl. Acad. Sci. U.S.A 1999, 96:11631-11636.
37. Mesulam M. The cholinergic innervation of the human cerebral cortex. Prog. Brain Res. 2004, 145:67-78.
38. Mesulam M., Shaw P., Mash D., Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann. Neurol. 2004, 55:815-828.
39. Molnár Z., Soós K., Lengyel I., Penke B., Szegedi V., Budai D. Enhancement of NMDA responses by [beta]-amyloid peptides in the hippocampus invivo. Neuroreport 2004, 15:1649-1652.
40. Morris J., Heyman A., Mohs R., Hughes J., van Belle G., Fillenbaum G., Mellits E., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease. Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
41. Murchison D., Griffith W. Calcium buffering systems and calcium signaling in aged rat basal forebrain neurons. Aging Cell 2007, 6:297-305.
42. Murrey H., Gama C., Kalovidouris S., Luo W.I., Driggers E., Porton B., Hsieh-Wilson L. Protein fucosylation regulates synapsin Ia/Ib expression and neuronal morphology in primary hippocampal neurons. Pro Natl. Acad. Sci. U.S.A 2006, 103:21-26.
43. Nairn A., Hemmings H., Greengard P. Protein kinases in the brain. Annu. Rev. Biochem. 1985, 54:931-976.
44. Nicolas G., Fournier C., Galand C., Malbert-Colas L., Bournier O., Kroviarski Y., Bourgeois M., Camonis J., Dhermy D., Grandchamp B., Lecomte M. Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain. Mol. Cell Biol. 2002, 22:3527-3536.
45. Oestreicher A., De Graan P., Gispen W., Verhaagen J., Schrama L. B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. Prog. Neurobiol. 1997, 53:627-686.
46. Riascos D., de Leon D., Baker-Nigh A., Nicholas A., Yukhananov R., Bu J., Wu C., Geula C. Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease. Acta Neuropathol. 2011, 122:565-576.
47. Saito K., Elce J., Hamos J., Nixon R. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Pro Natl. Acad. Sci. U.S.A 1993, 90:2628-2632.
48. Sakagami H., Kamata A., Nishimura H., Kasahara J., Owada Y., Takeuchi Y., Watanabe M., Fukunaga K., Kondo H. Prominent expression and activity-dependent nuclear translocation of Ca2+/calmodulin-dependent protein kinase Iδ in hippocampal neurons. Eur. J. Neurosci. 2005, 22:2697-2707.
49. Scharfman H., Schwartzkroin P. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 1989, 246:257-260.
50. Senga Y., Nagamine T., Kameshita I., Sueyoshi N. Knockdown of two splice variants of Ca (2+)/calmodulin-dependent protein kinase Iδ causes developmental abnormalities in zebrafish, Danio rerio. Arch. Biochem. Biophys. 2012, 517:71-82.
51. Shaywitz A., Greenberg M. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 1999, 68:821-861.
52. Srivastava T., Fortin D., Nygaard S., Kaech S., Sonenberg N., Edelman A., Soderling T. Regulation of neuronal mRNA translation by CaM-kinase I phosphorylation of eIF4GII. J.Neurosci. 2012, 32:5620-5630.
53. Tortosa A., Ferrer I. Poor correlation between delayed neuronal death induced by transient forebrain ischemia, and immunoreactivity for parvalbumin and calbindin D-28k in developing gerbil hippocampus. Acta Neuropathol. 1994, 88:67-74.
54. Tremper-Wells B., Vallano M. Nuclear calpain regulates Ca2+-dependent signaling via proteolysis of nuclear Ca2+/calmodulin-dependent protein kinase type IV in cultured neurons. J.Biol. Chem. 2005, 280:2165-2175.
55. Tsai S., Yang L., Wu C., Chang S., Hsu C., Wei C., Leu S., Liaw J., Lee Y., Tsai M. Injury-induced Janus kinase/protein kinase C-dependent phosphorylation of growth-associated protein 43 and signal transducer and activator of transcription 3 for neurite growth in dorsal root ganglion. J.Neurosci. Res. 2007, 85:321-331.
56. Verploegen S., Lammers J., Koenderman L., Coffer P. Identification and characterization of CKLiK, a novel granulocyte Ca (++)/calmodulin-dependent kinase. Blood 2000, 96:3215-3223.
57. Wang K., Villalobo A., Roufogalis B. Calmodulin-binding proteins as calpain substrates. Biochem. J. 1989, 262:693-706.
58. Wayman G., Lee Y., Tokumitsu H., Silva A., Soderling T. Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron 2008, 59:914-931.
59. Wee L., Tan T., Ranganathan S. SVM-based prediction of caspase substrate cleavage sites. BMC Bioinformatics 2006, 7(Suppl 5):S14.
60. Wu C., Mesulam M., Geula C. Age-related loss of calbindin from human basal forebrain cholinergic neurons. Neuroreport 1997, 8:2209-2213.
61. Wu C., Nagykery N., Hersh L., Scinto L., Geula C. Selective age-related loss of calbindin-D28k from basal forebrain cholinergic neurons in the common marmoset (Callithrix jacchus). Neuroscience 2003, 120:249-259.
62. Zakharov V., Bogdanova M., Mosevitsky M. Specific proteolysis of neuronal protein GAP-43 by calpain: characterization, regulation, and physiological role. Biochemistry (Mosc) 2005, 70:897-907.
63. Zakharov V., Mosevitsky M. M-calpain-mediated cleavage of GAP-43 near Ser41 is negatively regulated by protein kinase C, calmodulin and calpain-inhibiting fragment GAP-43-3. J.Neurochem. 2007, 101:1539-1551.